1)- Min Seo Choi, Jee Suk Chang, Kyubo Kim, Jin Hee Kim, Tae Hyung Kim, Sungmin Kim, Hyejung Cha, Oyeon Cho, Jin Hwa Choi, Myungsoo Kim, Juree Kim, Tae Gyu Kim, Seung-Gu Yeo, Ah Ram Chang, Sung-Ja Ahn, Jinhyun Choi, Ki Mun Kang, Jeanny Kwon, Taeryool Koo, Mi Young Kim, Seo Hee Choi, Bae Kwon Jeong, Bum-Sup Jang, In Young Jo, Hyebin Lee, Nalee Kim, Hae Jin Park, Jung Ho Im, Sea-Won Lee, Yeona Cho, Sun Young Lee, Ji Hyun Chang, Jaehee Chun, Eung Man Lee, Jin Sung Kim, Kyung Hwan Shin, Yong Bae Kim. Assessment of deep learning-based auto-contouring on interobserver consistency in target volume and organs-at-risk delineation for breast cancer: Implications for RTQA program in a multi-institutional study.Breast (Edinburgh, Scotland). 2023, 73: 103599
2)- T Blackmore, K Norman, V Burrett, J Scarlet, I Campbell, R Lawrenson. Key factors in the decision-making process for mastectomy alone or breast reconstruction: A qualitative analysis.Breast (Edinburgh, Scotland). 2023, 73: 103600
3)- Matteo Ghilli, Andrea Vittorio Emanuele Lisa, Marzia Salgarello, Giovanni Papa, Mario Rietjens, Secondo Folli, Annalisa Curcio, Guglielmo Ferrari, Francesco Caruso, Vittorio Altomare, Daniele Friedman, Maria Carmen De Santis, Fiorenza De Rose, Bruno Meduri, Francesca De Felice, Lorenza Marino, Francesca Cucciarelli, Stefania Montemezzi, Pietro Panizza, Paolo Belli, Francesca Caumo, Valeriano Vinci, Giorgio De Santis, Marco Klinger, Manuela Roncella, . Oncoplastic and reconstructive surgery in SENONETWORK Italian breast centers: lights and shadows.Breast (Edinburgh, Scotland). 2023, 73: 103601
4)- Pavla Ticha, Andrej Sukop. Patient-reported outcomes in bilateral prophylactic mastectomy with breast reconstruction: A narrative review.Breast (Edinburgh, Scotland). 2023, 73: 103602
5)- Yanyu Zhang, Xiaoxi Huang, Xingxing Yu, Wei He, Kamila Czene, Haomin Yang. Hematological and biochemical markers influencing breast cancer risk and mortality: Prospective cohort study in the UK Biobank by multi-state models.Breast (Edinburgh, Scotland). 2023, 73: 103603
6)- Masahiro Ito, Masakazu Amari, Akiko Sato, Masahiro Hikichi, Aru Sakamoto, Asumi Yamazaki, Shigehira Saji. Risk factors for late recurrence and postrelapse survival in estrogen receptor (ER)-positive, human epidermal growth factor receptor (HER) 2-negative breast cancer after 5 years of endocrine therapy.Breast (Edinburgh, Scotland). 2023, 73: 103604
7)- Maartje A C Schreurs, Teresa Ramón Y Cajal, Muriel A Adank, J Margriet Collée, Antoinette Hollestelle, Jeroen van Rooij, Marjanka K Schmidt, Maartje J Hooning. The benefit of adding polygenic risk scores, lifestyle factors, and breast density to family history and genetic status for breast cancer risk and surveillance classification of unaffected women from germline CHEK2 c.1100delC families.Breast (Edinburgh, Scotland). 2023, 73: 103611
8)- Kelvin Kh Bao, Jeffrey Ch Chan, Jocelyn G Chan, Leone Sutanto, Ka Man Cheung, Harry Hy Yiu. Real-world impact of dual anti-HER2 antibodies on cardiac function in patients with human epidermal growth factor receptor 2-positive metastatic breast cancer.Breast (Edinburgh, Scotland). 2023, 73: 103612
9)- Sandrine Hild, Delphine Teigné, Damien Fairier, Yannick Ruelle, Isabelle Aubin-Auger, Stéphanie Sidorkiewicz, Marie Citrini, Xavier Gocko, Catherine Cerisey, Emilie Ferrat, Cédric Rat. Development and evaluation of a decision aid for women eligible for organized breast cancer screening according to international standards: A multi-method study.Breast (Edinburgh, Scotland). 2023, 73: 103613
10)- Emma Söderberg, Fredrik Wärnberg, Anna-Karin Wennstig, Greger Nilsson, Hans Garmo, Lars Holmberg, Carl Blomqvist, Malin Sund, Charlotta Wadsten. Association of clinicopathologic variables and patient preference with the choice of surgical treatment for early-stage breast cancer: A registry-based study.Breast (Edinburgh, Scotland). 2023, 73: 103614
11)- Anja Tüchler, Antoine De Pauw, Corinna Ernst, Amélie Anota, Inge M M Lakeman, Julia Dick, Nienke van der Stoep, Christi J van Asperen, Monika Maringa, Natalie Herold, Britta Blümcke, Robert Remy, Anke Westerhoff, Denise J Stommel-Jenner, Eléonore Frouin, Lisa Richters, Lisa Golmard, Nadine Kütting, Chrystelle Colas, Barbara Wappenschmidt, Kerstin Rhiem, Peter Devilee, Dominique Stoppa-Lyonnet, Rita K Schmutzler, Eric Hahnen. Clinical implications of incorporating genetic and non-genetic risk factors in CanRisk-based breast cancer risk prediction.Breast (Edinburgh, Scotland). 2023, 73: 103615
12)- Irina Palimaru Manhoobi, Trine Tramm, Søren Redsted, Anne Bodilsen, Leslie Foldager, Peer Christiansen. Digital breast tomosynthesis versus X-ray of the breast specimen for intraoperative margin assessment: A randomized trial.Breast (Edinburgh, Scotland). 2023, 73: 103616
14)- Kadri Altundag. Is there a link between elevated C-reactive protein levels and specific breast cancer molecular subtypes?Breast (Edinburgh, Scotland). 2023, 73: 103621